Positions

Selected Publications

Academic Article

Year Title Altmetric
2018 Declining Financial Capacity in Mild Cognitive Impairment: A Six-Year Longitudinal Study.  Archives of Clinical Neuropsychology.  34:152-161. 2018
2018 Exploring the Factor Structure of Financial Capacity in Cognitively Normal and Impaired Older Adults 2018
2017 Financial Capacity and its Cognitive Predictors in Progressive Multiple Sclerosis.  Archives of Clinical Neuropsychology.  32:943-950. 2017
2017 Genetic influences on cognition in progressive supranuclear palsy.  Movement Disorders.  32:1764-1771. 2017
2017 The Neuropsychology (Broadly Conceived) of Multiple System Atrophy, Progressive Supranuclear Palsy, and Corticobasal Degeneration.  Archives of Clinical Neuropsychology.  32:861-875. 2017
2017 Medical decision-making capacity and its cognitive predictors in progressive MS: Preliminary evidence.  Journal of the Neurological Sciences.  380:38-43. 2017
2017 Interventions for cognitive deficits in breast cancer survivors treated with chemotherapy.  Cancer Nursing.  40:E11-E27. 2017
2017 Neurocognitive Predictors of Declining Financial Capacity in Persons with Mild Cognitive Impairment 2017
2017 White Matter Degradation is Associated with Reduced Financial Capacity in Mild Cognitive Impairment and Alzheimer's Disease.  Journal of Alzheimer's Disease.  60:537-547. 2017
2016 Twelve-month recovery of medical decision-making capacity following traumatic brain injury.  Neurology.  87:1052-1059. 2016
2016 Age and education corrected older adult normative data for a short form version of the financial capacity instrument.  Psychological Assessment.  28:737-749. 2016
2016 Enhancing Medical Decision-Making Evaluations: Introduction of Normative Data for the Capacity to Consent to Treatment Instrument.  Assessment.  23:232-239. 2016
2016 Introducing demographic corrections for the 10/36 Spatial Recall Test.  International Journal of Geriatric Psychiatry.  31:410-415. 2016
2015 Capacity of patients with brain metastases to make treatment decisions 2015
2015 Mild cognitive impairment: A history and the state of current diagnostic criteria.  International Psychogeriatrics.  27:199-211. 2015
2015 Cognitive Predictors of Reasoning through Treatment Decisions in Patients with Newly Diagnosed Brain Metastases.  Journal of the International Neuropsychological Society.  21:412-418. 2015
2015 Cognitive predictors of understanding treatment decisions in patients with newly diagnosed brain metastasis.  Cancer.  121:2013-2019. 2015
2015 Impairment of medical decisional capacity in relation to Karnofsky Performance Status in adults with malignant brain tumor 2015
2014 Cognition in patients with newly diagnosed brain metastasis: Profiles and implications.  Journal of Neuro-Oncology.  120:179-185. 2014
2014 Tracking the Cognition of Nursing Home Residents 2014
2013 Behavioral abnormalities in progressive supranuclear palsy.  Psychiatry Research.  210:1205-1210. 2013
2013 Measuring mild cognitive impairment in patients with Parkinson's disease.  Movement Disorders.  28:626-633. 2013
2013 Executive dysfunction is the primary cognitive impairment in progressive supranuclear palsy.  Archives of Clinical Neuropsychology.  28:104-113. 2013
2013 Functional impairment in progressive supranuclear palsy.  Neurology.  80:380-384. 2013

Chapter

Year Title Altmetric
2012 Aging, Rehabilitation, and Psychology 2012
2010 Screening Instruments and Brief Batteries for Dementia.  503-530. 2010
2010 Neuropsychiatric and cognitive disorders in other Parkinsonian disorders.  261-274. 2010

Education And Training

  • Doctor of Psychology in Clinical Psychology, University of Louisville 2014
  • Master of Psychology in Clinical Psychology, Murray State University 2007

    • Full Name

  • Adam Gerstenecker